488 related articles for article (PubMed ID: 25862711)
21. DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours.
Novelli M; Rossi S; Rodriguez-Justo M; Taniere P; Seddon B; Toffolatti L; Sartor C; Hogendoorn PC; Sciot R; Van Glabbeke M; Verweij J; Blay JY; Hohenberger P; Flanagan A; Dei Tos AP
Histopathology; 2010 Aug; 57(2):259-70. PubMed ID: 20716168
[TBL] [Abstract][Full Text] [Related]
22. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.
Rizzo FM; Palmirotta R; Marzullo A; Resta N; Cives M; Tucci M; Silvestris F
BMC Cancer; 2016 Feb; 16():87. PubMed ID: 26867653
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal stromal tumors and leiomyomas in the dog: a histopathologic, immunohistochemical, and molecular genetic study of 50 cases.
Frost D; Lasota J; Miettinen M
Vet Pathol; 2003 Jan; 40(1):42-54. PubMed ID: 12627712
[TBL] [Abstract][Full Text] [Related]
24. The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it.
Lee CH; Liang CW; Espinosa I
Adv Anat Pathol; 2010 May; 17(3):222-32. PubMed ID: 20418677
[TBL] [Abstract][Full Text] [Related]
25. Old and new immunohistochemical markers for the diagnosis of gastrointestinal stromal tumors.
González-Cámpora R; Delgado MD; Amate AH; Gallardo SP; León MS; Beltrán AL
Anal Quant Cytol Histol; 2011 Feb; 33(1):1-11. PubMed ID: 22125840
[TBL] [Abstract][Full Text] [Related]
26. Is DOG1 Immunoreactivity Specific to Gastrointestinal Stromal Tumor?
Swalchick W; Shamekh R; Bui MM
Cancer Control; 2015 Oct; 22(4):498-504. PubMed ID: 26678977
[TBL] [Abstract][Full Text] [Related]
27. ULTRASONOGRAPHIC FEATURES OF CANINE GASTROINTESTINAL STROMAL TUMORS COMPARED TO OTHER GASTROINTESTINAL SPINDLE CELL TUMORS.
Hobbs J; Sutherland-Smith J; Penninck D; Jennings S; Barber L; Barton B
Vet Radiol Ultrasound; 2015; 56(4):432-8. PubMed ID: 25846814
[TBL] [Abstract][Full Text] [Related]
28. PDGFRA and KIT Mutation Status and Its Association With Clinicopathological Properties, Including DOG1.
Baskin Y; Kocal GC; Kucukzeybek BB; Akbarpour M; Kayacik N; Sagol O; Ellidokuz H; Oztop I
Oncol Res; 2016; 24(1):41-53. PubMed ID: 27178821
[TBL] [Abstract][Full Text] [Related]
29. Clinical and immunohistochemical differentiation of gastrointestinal stromal tumors from leiomyosarcomas in dogs: 42 cases (1990-2003).
Russell KN; Mehler SJ; Skorupski KA; Baez JL; Shofer FS; Goldschmidt MH
J Am Vet Med Assoc; 2007 May; 230(9):1329-33. PubMed ID: 17472558
[TBL] [Abstract][Full Text] [Related]
30. DOG1 immunoreactivity in uterine leiomyosarcomas.
Sah SP; McCluggage WG
J Clin Pathol; 2013 Jan; 66(1):40-3. PubMed ID: 23038686
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
Miettinen M; Sobin LH; Sarlomo-Rikala M
Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical staining characteristics of canine gastrointestinal stromal tumors.
LaRock RG; Ginn PE
Vet Pathol; 1997 Jul; 34(4):303-11. PubMed ID: 9240839
[TBL] [Abstract][Full Text] [Related]
33. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus: a clinicopathologic, immunohistochemical, and molecular genetic study of 144 cases.
Miettinen M; Furlong M; Sarlomo-Rikala M; Burke A; Sobin LH; Lasota J
Am J Surg Pathol; 2001 Sep; 25(9):1121-33. PubMed ID: 11688571
[TBL] [Abstract][Full Text] [Related]
34. Outcome, prognostic factors and histological characterization of canine gastrointestinal sarcomas.
Del Alcazar CM; Mahoney JA; Dittrich K; Stefanovski D; Church ME
Vet Comp Oncol; 2021 Sep; 19(3):578-586. PubMed ID: 33774909
[TBL] [Abstract][Full Text] [Related]
35. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract.
Rossi G; Valli R; Bertolini F; Marchioni A; Cavazza A; Mucciarini C; Migaldi M; Federico M; Trentini GP; Sgambato A
Histopathology; 2005 May; 46(5):522-31. PubMed ID: 15842634
[TBL] [Abstract][Full Text] [Related]
36. Discovered on gastrointestinal stromal tumor 1, a keystone in the diagnosis of extraintestinal gastrointestinal stromal tumors.
Sahu KK; Tapadia R; Kini JR; Pai RR; Kini H; Nirupama M; Pooja KS
J Cancer Res Ther; 2019; 15(1):138-141. PubMed ID: 30880769
[TBL] [Abstract][Full Text] [Related]
37. Mutation assay of the novel gene DOG1 in gastrointestinal stromal tumors (GISTs).
Miwa S; Nakajima T; Murai Y; Takano Y; Sugiyama T
J Gastroenterol; 2008; 43(7):531-7. PubMed ID: 18648740
[TBL] [Abstract][Full Text] [Related]
38. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases.
Miettinen M; Monihan JM; Sarlomo-Rikala M; Kovatich AJ; Carr NJ; Emory TS; Sobin LH
Am J Surg Pathol; 1999 Sep; 23(9):1109-18. PubMed ID: 10478672
[TBL] [Abstract][Full Text] [Related]
39. Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract.
Coco DP; Hirsch MS; Hornick JL
Am J Surg Pathol; 2009 Dec; 33(12):1795-801. PubMed ID: 19950405
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
Ríos-Moreno MJ; Jaramillo S; Pereira Gallardo S; Vallejo A; Mora M; García-Escudero A; Amérigo J; González-Cámpora R
Pathol Res Pract; 2012 Feb; 208(2):74-81. PubMed ID: 22197035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
